Nurix Therapeutics (NRIX)
NASDAQ:NRIX
US Market
Holding NRIX?
Track your performance easily

Nurix Therapeutics (NRIX) Income Statement

401 Followers

Nurix Therapeutics Income Statement

Last quarter (Q3 2024), Nurix Therapeutics's total revenue was $12.59M, a decrease of -31.84% from the same quarter last year. In Q3, Nurix Therapeutics's net income was $-48.96M. See Nurix Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Nov 23Nov 22Nov 21Nov 20Nov 19
Total Revenue
$ 56.42M$ 76.99M$ 38.63M$ 29.75M$ 17.82M$ 31.11M
Cost of Revenue
------
Gross Profit
$ 56.42M$ 76.99M$ 38.63M$ 29.75M$ 17.82M-
Operating Expense
$ 250.13M$ 232.05M$ 222.49M$ 147.64M$ 82.80M$ 53.35M
Operating Income
$ -193.70M$ -155.06M$ -183.87M$ -117.89M$ -64.98M$ -22.24M
Net Non Operating Interest Income Expense
$ 16.99M$ 11.12M$ 3.51M$ 823.00K$ 1.21M$ 776.00K
Other Income Expense
----$ -15.11M-
Pretax Income
$ -176.71M$ -143.95M$ -180.36M$ -117.06M$ -63.78M$ -21.46M
Tax Provision
$ 262.00K--$ 131.00K$ -20.54M$ 239.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -176.98M$ -143.95M$ -180.36M$ -117.19M$ -43.24M$ -21.70M
Basic EPS
$ -2.91$ -2.65$ -3.71$ -2.73$ -2.76$ -1.35
Diluted EPS
$ -2.91$ -2.65$ -3.71$ -2.73$ -2.76$ -1.35
Basic Average Shares
$ 244.73M$ 54.34M$ 48.61M$ 42.90M$ 15.67M$ 16.11M
Diluted Average Shares
$ 244.73M$ 54.34M$ 48.61M-$ 15.67M$ 16.11M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 250.13M$ 232.05M$ 222.49M$ 147.64M$ 82.80M$ 53.35M
Net Income From Continuing And Discontinued Operation
$ -176.98M$ -143.95M$ -180.36M$ -117.19M$ -43.24M$ -21.70M
Normalized Income
$ -133.41M--$ -92.48M-$ -21.70M
Interest Expense
------
EBIT
$ -180.50M$ -143.95M$ -183.87M$ -117.89M$ -64.98M$ -22.24M
EBITDA
$ -159.27M$ -130.33M$ -173.06M$ -111.80M$ -62.80M$ -19.88M
Currency in USD

Nurix Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis